Transcatheter closure of atrial septal defects

Expert Review of Cardiovascular Therapy

Volumn 2, Issue 5, 2004, Pages 713-719

  Gupta, Anuja ^a   Kapoor, Gaurav ^b   Dalvi, Bharat ^c  

^a KEM HOSPITAL   (India)

^b Farmington Heart Center   (United States)

^c Glenmark Cardiac Centre   (India)

Author keywords

Atrial septal defects; Device closure; Percutaneous closure; Transcatheter closure

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CLOPIDOGREL; FIBRINOLYTIC AGENT; NICKEL; WARFARIN;

ATRIOVENTRICULAR BLOCK; BACTERIAL ENDOCARDITIS; CEREBROVASCULAR ACCIDENT; CLIP; CONTROLLED STUDY; DEVICE; EMBOLISM; FATALITY; FISTULA; HEADACHE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART TAMPONADE; HEMOPERICARDIUM; HUMAN; LUNG EDEMA; MORBIDITY; NEUROSIS; PERICARDIAL EFFUSION; POSTOPERATIVE COMPLICATION; REVIEW; SAFETY; SEIZURE; SUDDEN DEATH; SURGICAL APPROACH; SURGICAL TECHNIQUE; THROMBOEMBOLISM; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; VISUAL IMPAIRMENT;

BALLOON OCCLUSION; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS;

EID: 4544344499     PISSN: 14779072     EISSN: None     Source Type: Journal    
DOI: 10.1586/14779072.2.5.713     Document Type: Review

References (53)

1. Ebeid MR. Percutaneous catheter closure of secundum atrial septal defects: a review. J. Invasive Cardiol. 14, 25-31 (2002).
2. Rigby ML. The era of transcatheter closure of atrial septal defects. Heart 81, 227-228 (1999).
3. Schrader R. Catheter closure of secundum ASD using 'other' devices. J. Interv. Cardiol. 16, 409-412 (2003).
4. Omeish A, Hijazi ZM. Transcatheter closure of atrial septal defects in children and adults using the Amplatzer septal occluder. J. Interv. Cardiol. 14, 37-44 (2001).
5. Zahn EM, Wilson N, Cutright W, Latson LA. Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system. Circulation 104, 711-716 (2001).
6. Carminati M, Chessa M, Butera G et al. Transcatheter closure of atrial septal defects with the STARflex device: early results and follow-up. J. Interv. Cardiol. 14, 319-324 (2001).
7. Pedra CAC, Pihkala J, Lee KJ et al. Transcatheter closure of atrial septal defects using the CardioSEAL implant. Heart 84, 320-326 (2000).
8. Rao PS, Berger F, Rey C et al. Results of transvenous occlusion of secundum atrial septal defects with the fourth generation buttoned device: comparison with first, second and third generation devices. International Buttoned Device Trial Group. J. Am. Coll. Cardiol. 36, 583-592 (2000).
9. Rickers C, Hamm C, Stern H et al. Percutaneous closure of secundum atrial septal defect with a new selfcentering device ('AngelWings'). Heart 80, 517-521 (1998).
10. Sievert H, Babic U, Hausdorf G et al. Transcatheter closure of atrial septal defect and patent foramen ovale with the ASDOS device (a multi-institutional European trial). Am. J. Cardiol. 82, 1405-1413 (1998).
11. Durongpisitkul K, Tang NL, Soongswang J, Laohaprasitiporn D, Nanal A. Predictors of successful transcatheter closure of atrial septal defect by cardiac magnetic resonance imaging. Pediatr. Cardiol. 25(2), 124-130 (2004).
12. Varma C, Benson L, Silversides C et al. Outcomes and alternative techniques for device closure of the large secundum atrial septal defect. Catheter Cardiovasc. Interv. 61, 131-139 (2004).
13. Roman KS, Jones A, Keeton BR, Salmon AP. Different techniques for closure of multiple interatrial communications with the Amplatzer septal occluder. J. Interv. Cardiol. 15, 393-397 (2002).
14. Szkutnik M, Masura J, Bialkowski J et al. Transcatheter closure of double atrial septal defects with a single Amplatzer device. Catheter Cardiovasc. Interv. 61, 237-241 (2004).
15. Carano N, Hagler DJ, Agnetti A, Squarcia U. Device closure of fenestrated atrial septal defects: use of a single Amplatzer atrial septal occluder after balloon atrial septostomy to create a single defect. Catheter Cardiovasc. Interv. 52, 203-207 (2001).
16. Rodriguez M, de Lezo JS, Pan M et al. Percutaneous closure of large atrial septal defects. Rev. Esp. Cardiol. 56, 888-893 (2003).
17. de Lezo JS, Medina A, Romero M et al. Effectiveness of percutaneous device occlusion for atrial septal defect in adults with pulmonary hypertension. Am. Heart J. 144, 877-880 (2002).
18. Onorato E, Pera J, Lanzone A et al. Transcatheter treatment of coronary artery disease and atrial septal defect with sequential implantation of coronary stent and Amplatzer septal occluder. preliminary results. Catheter Cardiovasc. Interv. 54, 454-458 (2001).
19. Vogel M, Berger F, Dahnert I, Ewert P, Lange PE. Treatment of atrial septal defects in symptomatic children aged less than 2 years of age using the Amplatzer septal occluder. Cardiol. Young 10, 534-537 (2000).
20. Murphy JG, Gersh BJ, McGoon MD et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N. Engl. J. Med. 323, 1645-1650 (1990).
21. Du HD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Amplatzer Investigators. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J. Am. Coll. Cardiol. 39, 1836-1844 (2002).
22. Berger F, Vogel M, Alexi-Meskishvili V, Lange PE. Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects. J. Thorac. Cardiovasc. Surg. 118, 674-680 (1999).
23. Thomson JDR, Aburawi EH, Watterson KG, Van Doorn C, Gibbs JL. Surgical and transcatheter (Amplatzer) closure of atrial septal defects: a prospective comparison of results and cost. Heart 87, 466-469 (2002).
24. Hughes ML, Maskell G, Goh TH, Wilkinson JL. Prospective comparison of costs and short-term health outcomes of surgical versus device closure of atrial septal defect in children. Heart 87, 67-70 (2002).
25. Cowley CG, Lloyd TR, Bove EL, Gaffney D, Dietrich M, Rocchini AP. Comparison of results of closure of secundum atrial septal defect by surgery versus Amplatzer septal occluder. Am. J. Cardiol. 88, 589-591 (2001).
26. King TD, Mills NL. Secundum atrial septal defects: nonoperative closure during cardiac catheterizations. J. Am. Med. Assoc. 235, 2506-2509 (1976).
27. Rashkind WJ. Transcatheter treatment of congenital heart diseases. Circulation 67, 711-716 (1983).
28. Babic UU, Grujicic S, Djurisic Z, Vucinic M, Pejcic P. Double-umbrella device for transvenous closure of patent ductus arteriosus and atrial septal defect: first experience. J. Interv. Cardiol. 4, 283-294 (1991).
29. Sideris EB, Sideris SE, Fowlkes JP, Ehly RL, Smith JE, Gulde RE. Transvenous atrial septal defect occlusion in piglets with a 'buttoned' double disk device. Circulation 81, 312-318 (1990).
30. Prieto LR, Foreman CK, Cheatham JP, Latson LA. Intermediate-term outcome of transcatheter secundum atrial septal defect using the Bard clamshell septal umbrella. Am. J. Cardiol. 78, 1310-1312 (1996).
31. Das GS, Voss G, Jarvis G, Wyche K, Gunther R, Wilson RF. Experimental atrial septal defect closure with a new, transcatheter, self-centering device. Circulation 88, 1754-1764 (1993).
32. Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: initial human axperience. Cathet. Cardiovasc. Diagn. 42, 388-393 (1997).
33. Sideris EB, Leung M, Yoon JH et al. Occlusion of Large atrial septal defects with a centering buttoned device: early clinical experience. Am. Heart J. 131, 356-359 (1996).
34. Latson LA. The CardioSEAL device: history, techniques, results. J. Interv. Cardiol. 11, 501-505 (1997).
35. Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart 89, 199-204 (2003).
36. Chessa M, Carminati M, Butera G et al. Early and late complications associated with transcather occlusion of secundum atrial septal defects. J. Am. Coll. Cardiol. 39, 1061-1065 (2002).
37. Prewitt KC, Gaither NS, Farb A, Wortham DC. Transient ischemic attacks after long-term Clamshell occluder implantation for closure of atrial septal defects. Am. Heart J. 124, 1394-1397 (1992).
38. Krumsdorf U, Ostermayer S, Billinger K et al. Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices in 1000 consecutive patients. J. Am. Coll. Cardiol. 43, 302-309 (2004).
39. Berger F, Ewert P, Abdul-Khaliq H, Nurnberg JH, Lange PE. Percutaneous closure of large atrial septal defects with the Amplatzer septal occluder: technical overkill or recommendable alternative treatment. J. Interv. Cardiol. 14, 63-67 (2001).
40. Chun DS, Turrentine MW, Moustapha A, Hoyer MH. Development of aorta-to-right atrial fistula following closure of secundum atrial septal defect using the Amplatzer septal occluder. Catheter Cardiovasc. Interv. 58, 246-251 (2003).
41. Ries MW, Kampmann C, Rupprecht HJ, Hintereder G, Hafner G, Meyer J. Nickel release after implantation of the Amplatzer occluder. Am. Heart J. 145, 737-731 (2003).
42. Landzberg M, Khairy P. Indications for closure of patent foramen ovale. Heart 90, 219-224 (2004).
43. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann. Intern. Med. 4, 753-760 (2003).
44. Meier B, Lock JE. Contemporary management of patent foramen ovale. Circulation 107, 5-9 (2003).
45. Mohr JP, Homma S. Patent cardiac foramen ovale: stroke risk and closure. Ann. Intern. Med. 139, 787-788 (2003).
46. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French study group on patent foramen ovale and atrial septal aneurysm. Am. Heart J. 130, 1083-1088 (1995).
47. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann. Intern. Med. 117, 461-465 (1992).
48. Mohr JP. Cryptogenic stroke. N. Engl. J. Med. 318, 1197-1198 (1988).
49. Mas JL, Arquizan C, Lamy C et al. Patent foramen ovale and atrial septal aneurysm study group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N. Engl. J. Med. 345, 1740-1746 (2001).
50. De Castro S, Cartoni D, Fiorelli M et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 31, 2407-2413 (2000).
51. Knauth M, Ries S, Pohimann S et al. Cohort study of multiple brain lesions in sport divers: role of a patent foramen ovale. Br. Med. J. 314, 701-705 (1997).
52. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for hemodynamic reasons. Lancet 356, 1648-1651 (2000).
53. Cheng TO. Platypnea-orthodeoxia syndrome: etiology, differential diagnosis, and management. Catheter Cardiovasc Interv. 47, 64-66 (1999).